These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 15693891

  • 1. HDM2 overexpression and focal loss of p14/ARF expression may deregulate the p53 tumour suppressor pathway in meningeal haemangiopericytomas. Study by double immunofluorescence and laser scanning confocal microscopy.
    Martínez JC, Palomino JC, Cabello A, Sepúlveda JM, de la Cámara AG, Ricoy JR.
    Histopathology; 2005 Feb; 46(2):184-94. PubMed ID: 15693891
    [Abstract] [Full Text] [Related]

  • 2. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ, Zhu MH, Ni CR, Li FM, Zheng JM, Gong ZJ.
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [Abstract] [Full Text] [Related]

  • 3. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
    García JF, Villuendas R, Sánchez-Beato M, Sánchez-Aguilera A, Sánchez L, Prieto I, Piris MA.
    Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
    [Abstract] [Full Text] [Related]

  • 4. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
    Stürzenhofecker B, Schlott T, Quentin T, Kube D, Jung W, Trümper L.
    Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
    [Abstract] [Full Text] [Related]

  • 5. Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy.
    Martinez JC, Palomino JC, Samaniego R, Sepulveda JM, Cabello A, Ricoy JR.
    Cancer; 2008 Jul 01; 113(1):166-74. PubMed ID: 18459177
    [Abstract] [Full Text] [Related]

  • 6. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
    Kumamoto H, Izutsu T, Ohki K, Takahashi N, Ooya K.
    J Oral Pathol Med; 2004 May 01; 33(5):292-9. PubMed ID: 15078490
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
    Kanavaros P, Bai M, Stefanaki K, Poussias G, Rontogianni D, Zioga E, Gorgoulis V, Agnantis NJ.
    Histol Histopathol; 2001 Apr 01; 16(2):377-86. PubMed ID: 11332692
    [Abstract] [Full Text] [Related]

  • 8. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma.
    Mori S, Ito G, Usami N, Yoshioka H, Ueda Y, Kodama Y, Takahashi M, Fong KM, Shimokata K, Sekido Y.
    Cancer; 2004 Apr 15; 100(8):1673-82. PubMed ID: 15073856
    [Abstract] [Full Text] [Related]

  • 9. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA, Kalish LH, Nguyen TV, Kench JG, Bova RJ, Cole IE, Musgrove EA, Sutherland RL.
    Clin Cancer Res; 2005 Jun 01; 11(11):4107-16. PubMed ID: 15930346
    [Abstract] [Full Text] [Related]

  • 10. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
    Giannikaki E, Kouvidou C, Tzardi M, Stefanaki K, Koutsoubi K, Gregoriou M, Zois E, Kakolyris S, Mavroudi C, Delides G, Georgoulias V, Kanavaros P.
    Anticancer Res; 1997 Jun 01; 17(3C):2123-7. PubMed ID: 9216675
    [Abstract] [Full Text] [Related]

  • 11. p14(ARF) nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways.
    Sánchez-Aguilera A, Sánchez-Beato M, García JF, Prieto I, Pollan M, Piris MA.
    Blood; 2002 Feb 15; 99(4):1411-8. PubMed ID: 11830494
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Defining the molecular basis of Arf and Hdm2 interactions.
    Bothner B, Lewis WS, DiGiammarino EL, Weber JD, Bothner SJ, Kriwacki RW.
    J Mol Biol; 2001 Nov 23; 314(2):263-77. PubMed ID: 11718560
    [Abstract] [Full Text] [Related]

  • 15. Alterations of the p53, Rb and p27 tumor suppressor pathways in diffuse large B-cell lymphomas.
    Bai M, Tsanou E, Skyrlas A, Sainis I, Agnantis N, Kanavaros P.
    Anticancer Res; 2007 Nov 23; 27(4B):2345-52. PubMed ID: 17695524
    [Abstract] [Full Text] [Related]

  • 16. CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway.
    Kamrul HM, Wadhwa R, Kaul SC.
    Ann N Y Acad Sci; 2007 Apr 23; 1100():312-5. PubMed ID: 17460193
    [Abstract] [Full Text] [Related]

  • 17. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S, Jülicher KP, Burger MS, Della Valle V, Larsen CJ, Yeager TR, Grossman TB, Nickells RW, Protzel C, Jarrard DF, Reznikoff CA.
    Cancer Res; 2000 Jul 15; 60(14):3862-71. PubMed ID: 10919661
    [Abstract] [Full Text] [Related]

  • 18. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
    Stefanaki K, Tzardi M, Kouvidou C, Chaniotis V, Bolioti M, Vlychou M, Zois M, Kakolyris S, Delides G, Rontogianni D, Georgoulias V, Kanavaros P.
    Anticancer Res; 1998 Jul 15; 18(4A):2403-8. PubMed ID: 9703886
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.